Airing

Airing is a manufacturing startup founded in 2014, dedicated to revolutionizing the way sleep apnea is treated. The company's flagship product is the world's first hoseless, maskless, cordless, micro-CPAP device. This innovation aims to address the common issue of patient non-compliance, as over 50% of diagnosed sleep apnea sufferers give up on their CPAP machine after only a few months. Airing's solution not only eliminates the hassle of dealing with hoses, masks, and cords but also offers soft, comfortable nose buds engineered to stay firmly in the nostril, forming a perfect seal without the need for straps. The convenience and ease of use provided by Airing's product make it ideal for traveling. The most recent milestone for Airing is the $1.35M Venture Round investment secured on 17 January 2018. This investment signifies the confidence of the investors in the potential of Airing's disruptive technology. With untreated sleep apnea posing significant health risks, Airing's innovative approach has the potential to liberate sleep apnea sufferers worldwide. As the company continues to make strides in reshaping the landscape of sleep apnea treatment, it is poised to make a considerable impact in the healthcare industry.